One focused working session plus a short written output - so you know the realistic Austrian picture, whether you are here to establish a company, relocate, or sell, before committing budget.
Choose a slot and pay the fixed fee. You get a short intake form immediately.
Tell us your product or plan, target sectors, and where you are today - so the session starts warm, not from zero.
A 90-minute call with your lead: structure, residence, market and the real obstacles, in proper German or English.
Within [ 5 ] working days: a short, decision-ready document you can act on or take to your board.
[ Name ], [ role ] - [ one-line credential: e.g. 15+ years in Austrian market entry, ex-[firm], led [n] company setups and reimbursement mandates ]. The person on the call is the person accountable for the output - not a junior handed the file afterwards.
No. Company setup, corporate structure and relocation are sector-agnostic - most of our Austrian work is exactly that. The reimbursement part (EKO) applies only if you are selling a regulated healthcare product; if not, we spend the session on structure, residence and go-to-market instead.
Austria is often the first step. Deep German pharma market access - AMNOG, G-BA, IQWiG - is run by our German practice at bcaun.de. The assessment maps the route on to Germany so the two connect cleanly.
Yes. The fixed assessment fee is credited against a follow-on engagement, so it is a low-risk way to start. [ confirm your exact terms ]
German or English, your choice. Local execution and correspondence in Austria is handled in proper German.